Trial intelligence / Profile preview

Carbaglu for Acute Hyperammonemia in PA and MMA

NCT01597440Phase 2Terminated

Start
Sep 2012
Primary completion
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of carglumic acid in propionic acidemia (PA), methylmalonic acidemia (MMA). Started Sep 2012; status: terminated.

02

Drugs

carglumic acid
03

Conditions

propionic acidemia (PA)methylmalonic acidemia (MMA)

Beyond the preview

Go deeper on NCT01597440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01597440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call